Doctors alerted over adverse reaction with shingles vaccine: case
The patient suffered a bullous drug eruption after her second dose of Shingrix, US doctors report.
Doctors are being urged to look out for bullous drug eruptions following administration of Australia’s newly recommended varicella zoster vaccine after the adverse reaction was seen in a US patient.
In July, Shingrix became the first choice for adults 50 or older under updated guidance from ATAGI and the National Centre for Immunisation Research and Surveillance.
